Highlights iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
10.78 ^USD	-0.19%		-0.09%	-1.55%

Mar. 13	Top Premarket Decliners	MT
Mar. 12	JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ITeos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Iteos Therapeutics, Inc. Announces Business Updates and Strategic Priorities for 2024	Jan. 08	CI
ITeos Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
ITeos Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
ITeos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
ITeos Therapeutics Q4 Earnings Fall	23-03-15	MT
ITEOS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-15	AQ
ITEOS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-10	AQ
ITeos Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
ITEOS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-10	AQ
ITeos Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
ITeos Therapeutics Swings to Q1 Profit, Tops Street Estimates	22-05-12	MT
ITEOS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-05-12	AQ
ITeos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
GSK to buy Sierra Oncology amid pressure to boost drug pipeline	22-04-13	RE
ITeos Therapeutics Swings to Q4 Gain, Sees Funding Into 2026	22-03-23	MT
ITEOS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22-03-23	AQ
ITeos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-23	CI
ITEOS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21-11-10	AQ
ITeos Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Highlights

Filters